TNFRSF6B Gene

Last updated on: 26.05.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

TNFRSF6B (TNF Receptor Superfamily Member 6b), also called Decoy Receptor 3, is a protein-coding gene located on chromosome 20q13.33.

General informationThis section has been translated automatically.

This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is thought to play a regulatory role in the suppression of FasL- and LIGHT-mediated apoptosis. It functions as a decoy receptor (a decoy receptor (translatable as "mock receptor; decoy receptor" is a specific receptor that binds its ligand with high affinity but does not transmit signals) that competes with death receptors for ligand binding. Overexpression of this gene has been found in tumors of the gastrointestinal tract.

Diseases associated with TNFRSF6B include:

  • Proliferative extracapillary glomerulonephritis,also known as "Idiopathic Crescentic Glomerulonephritis", which usually presents clinically as Rapid progressive glomerulonephritis with hematuria, proteinuria and rapidly deteriorating renal function.

LiteratureThis section has been translated automatically.

  1. Siakavellas SI et al (2015) The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases. Semin Arthritis Rheum 45:1-8.
  2. Weng SC et al (2019) Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases. J Chin Med Assoc 82:680-684.

Last updated on: 26.05.2022